You just read:

NW Bio Announces Lifting of Clinical Hold on DCVax®-L Phase III Trial By FDA; Progression-Free Survival Events Reached; Overall Survival Events Not Yet Reached

News provided by

Northwest Biotherapeutics

06 Feb, 2017, 09:30 ET